Skip to content

Spectra WaveWriter™ SC-5160

by Boston Scientific Neuromodulation

Ref M365SC51600

Spectra WaveWriter™ SC-5160 is a device classified as Active implantable (AIMDD) (EU), Class III (US) made by Boston Scientific Neuromodulation, registered in EUDAMED on 5 Nov 2026 (Basic UDI-DI B-08714729952046), approved under FDA PMA P030017 on 27 Apr 2004 and listed in FDA GUDID since 5 Jun 2017 (UDI-DI 08714729952046), active as of 7 Nov 2026. 17 FDA recalls are linked to it.

Active European Union and United States. Also listed in GUDID (US).

CE AIMDD PMA

Valid until

No date given

CE: no date in EUDAMED. FDA: not time-limited

FDA recalls

3 ongoing

This device is named in the recall

Documents

None linked in EUDAMED

A group certificate may exist

PMA P030017

FDA submission, from GUDID

Trust

Unverified

Source EUDAMED, GUDID, synced 7 Nov 2026.

Regulatory status

as of registry sync 7 Nov 2026

RegionAuthorizationNumberDateStatus
European UnionCE/AIMDD EUDAMED NumberB-08714729952046 Basic UDI-DI 08714729952046UDI-DIDate5 Nov 2026RegisteredStatusActive
United StatesGUDID listing GUDID Number08714729952046 UDI-DI Date5 Jun 2017ListedStatusListed GUDID: in commercial distribution
United StatesFDA PMAAPPR GUDID from GUDID Approved NumberP030017 Date27 Apr 2004DecidedStatusActive

Official records

Across registries

3 registries list this device

  • EUDAMED Basic UDI-DI B-08714729952046 registered 5 Nov 2026 Active
  • FDA PMA P030017 decided 27 Apr 2004 Active
  • FDA GUDID UDI-DI 08714729952046 listed 5 Jun 2017 Listed

Recalls

17 recalls · 3 ongoing · FDA

    • Ongoing Z-2879-2026 FDA Class I initiated 17 Jun 2026

    Spinal cord stimulation system lead body may be exposed to stress at the anchor site. This may result in high impedance measurements or lead fractures, which may lead to inadequate stimulation, additional intervention, including lead explant and replacement.

    • Ongoing Z-2404-2026 FDA Class II initiated 29 Apr 2026

    Sterile anchors my lack sterility assurance.

    • Ongoing Z-2617-2024 FDA Class II initiated 17 Jul 2024

    Spinal Cord Stimulation (SCS) Implantable Pulse Generator (IPG) may experience routine system check during IPG charging, which may cause device reset, which may lead to transient loss of stimulation; patients may experience undesired sensations when therapy turns off for approx. 10-15 seconds and then back on, which may lead patient to request surgical intervention for replacement or revision.

  • 5 recalls, same reason

    • Terminated Z-2124-2020 FDA Class II initiated 24 Apr 2019
    • Terminated Z-2122-2020 FDA Class II initiated 24 Apr 2019
    • Terminated Z-2119-2020 FDA Class II initiated 24 Apr 2019
    • Terminated Z-2121-2020 FDA Class II initiated 24 Apr 2019
    • Terminated Z-2120-2020 FDA Class II initiated 24 Apr 2019

    The firm is initiating a voluntary removal of certain spinal cord stimulation leads, lead extensions, adapters, and deep brain stimulation lead extensions due to the "use by date" displayed on the label which is later than the correct "use by date". No adverse health consequence is expected to occur from this issue.

    • Terminated Z-2123-2020 FDA Class II initiated 24 Apr 2019

    The firm is initiating a voluntary removal of certain spinal cord stimulation leads, lead extensions, adapters, and deep brain stimulation lead extensions due to "use by date" displayed on the label which is later than the correct "use by date". No adverse health consequence is expected to occur from this issue.

    • Terminated Z-1409-2010 FDA Unclassified (pre-2012) initiated 19 Mar 2010

    Toshiba has determined that certain Sony battery packs installed in Toshiba portable computers can overheat, posing fire hazard to customers. Based on Toshiba's investigation with Sony Corporation, they concluded that the battery cells in specific manufacturing lots could be affected.

    • Terminated Z-0271-2009 FDA Unclassified (pre-2012) initiated 22 Sep 2008

    Since April 2004, 27 of 8,769 (0.31%) patients have reported receiving second degree burns in the area of charging and 3 of 8,769 (0.03%) patients have reported receiving third degree burns in the area of charging while using Charger 1 .0. Some of these events were the direct result of the patient disregarding the instructions for use, such as sleeping with the Charger on or placing it directly on

    • Terminated Z-1441-2012 FDA Unclassified (pre-2012) initiated 22 Apr 2008

    The recall was initiated because there is a possibility that the OMG Connector-A is incorrectly packaged with an OMG Connector-M Instruction manual.

    • Terminated Z-0960-2008 FDA Unclassified (pre-2012) initiated 5 Oct 2007

    Incorrect Data -- Corruption of internal memory component results in an inability for the physician to reprogram the IPG with firmware version prior to Revision 3.02. When this occurs, the IPG will report an error code of "10h0" or "00h0" through the Remote Control. Under this condition, the IPG will cease to log in some data that could be used for informational purposes. ** It should be noted t

    • Terminated Z-0055-2008 FDA Unclassified (pre-2012) initiated 3 Aug 2007

    Mislabeled: Product labeled with the incorrect shelf-life information.

    • Terminated Z-0700-2007 FDA Unclassified (pre-2012) initiated 30 Jan 2007

    The Precision Implantable Pulse Generator with firmware Revision 3.01 incorrectly reports an error condition for a valid output from its self internal check.

    • Terminated Z-0299-2007 FDA Unclassified (pre-2012) initiated 21 Sep 2006

    A small number of unimplanted Precision Linear Leads may have been assembled with incorrect electrode material. At high stimulation levels, the metal may corrode and dissolved metals may enter the patient.

    • Terminated Z-0396-05 FDA Unclassified (pre-2012) initiated 11 Nov 2004

    A burn injury was sustained by a patient that did not follow the directions for use and also slept while charging the unit.

Timeline

20 dated events

  1. Recall initiated FDA recalls Z-2124-2020
  2. Recall initiated FDA recalls Z-2122-2020
  3. Recall initiated FDA recalls Z-2119-2020
  4. Recall initiated FDA recalls Z-2123-2020
  5. Recall initiated FDA recalls Z-2121-2020
  6. Recall initiated FDA recalls Z-2120-2020
  7. Recall initiated FDA recalls Z-2617-2024
  8. Recall initiated FDA recalls Z-2404-2026
  9. Recall initiated FDA recalls Z-2879-2026
  10. Registered EUDAMED B-08714729952046

10 earlier events are in the sections above.

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/AIMDD Active
  • United States FDA PMA Active

Specification

EUDAMED · GUDID

Trade name
Spectra WaveWriter™
Generic name
Trial spinal cord/peripheral nerve percutaneous analgesic electrical stimulation system pulse generator
Device name
ETS Accessories
Model / reference
M365SC51600 EUDAMED
SC-5160 GUDID
Primary DI / UDI-DI
08714729952046
Basic UDI-DI
B-08714729952046
PMA number
FDA product code
LGW, QRB
EMDN code
J0299 Implantable neurostimulators - other
GMDN term
Trial spinal cord/peripheral nerve percutaneous analgesic electrical stimulation system pulse generator
Device class
Class AIMDD EUDAMED
Class III GUDID
EU registration type
Legacy device (under a directive)
EU market of registration
Netherlands
GUDID distribution status
In Commercial Distribution

Truth per registry

2 sources · 2 fields differ

FieldEUDAMEDGUDID
Model / referenceEUDAMED
M365SC51600
GUDID
SC-5160
Device classEUDAMED
Class AIMDD
GUDID
Class III

Device class is stated on each registry's own scale: Class AIMDD in the EU (EUDAMED), Class III in the US (FDA GUDID). EU and US classes are different schemes, so this is not a disagreement.

Similar devices in this category

Other devices filed under IMPLANTABLE NEUROSTIMULATORS.

Other devices from Boston Scientific Neuromodulation

See all devices from Boston Scientific Neuromodulation →

Properties

  • Prescription use
  • Lot / batch number
  • Serial number
Other properties (22, all answered No)